Nanobiotix S.A. (NANO.PA)

EUR 3.0

(-0.17%)

Operating Expenses Summary of Nanobiotix S.A.

  • Nanobiotix S.A.'s latest annual operating expenses in 2023 was 58.92 Million EUR , up 20.28% from previous year.
  • Nanobiotix S.A.'s latest quarterly operating expenses in 2024 Q2 was 32.94 Million EUR , down 0.0% from previous quarter.
  • Nanobiotix S.A. reported a annual operating expenses of 48.99 Million EUR in annual operating expenses 2022, up 1.54% from previous year.
  • Nanobiotix S.A. reported a annual operating expenses of 48.25 Million EUR in annual operating expenses 2021, up 29.76% from previous year.
  • Nanobiotix S.A. reported a quarterly operating expenses of 58.92 Million EUR for 2023 FY, up 20.28% from previous quarter.
  • Nanobiotix S.A. reported a quarterly operating expenses of 34.32 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Nanobiotix S.A. (2023 - 2011)

Historical Annual Operating Expenses of Nanobiotix S.A. (2023 - 2011)

Year Operating Expenses Operating Expenses Growth
2023 58.92 Million EUR 20.28%
2022 48.99 Million EUR 1.54%
2021 48.25 Million EUR 29.76%
2020 37.18 Million EUR -21.7%
2019 47.49 Million EUR 43.86%
2018 33.01 Million EUR 10.81%
2017 29.79 Million EUR 9.65%
2016 27.16 Million EUR 28.51%
2015 21.14 Million EUR 70.65%
2014 12.38 Million EUR 48.12%
2013 8.36 Million EUR 60.02%
2012 5.22 Million EUR -0.0%
2011 5.22 Million EUR 0.0%

Peer Operating Expenses Comparison of Nanobiotix S.A.

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -1310.75%
ABIVAX Société Anonyme 127.37 Million EUR 53.738%
Adocia SA 15.62 Million EUR -277.036%
Aelis Farma SA 18.81 Million EUR -213.125%
Biophytis S.A. 14.33 Million EUR -311.128%
Advicenne S.A. 8.21 Million EUR -617.31%
genOway Société anonyme 16.73 Million EUR -252.049%
IntegraGen SA 5.35 Million EUR -1000.923%
Medesis Pharma S.A. 1.56 Million EUR -3666.334%
Neovacs S.A. 10.34 Million EUR -469.698%
NFL Biosciences SA 4.37 Million EUR -1247.102%
Plant Advanced Technologies SA 2.76 Million EUR -2031.291%
Quantum Genomics Société Anonyme 1.71 Million EUR -3330.047%
Sensorion SA 27.05 Million EUR -117.815%
Theranexus Société Anonyme 3 Million EUR -1860.974%
TME Pharma N.V. 5.49 Million EUR -971.985%
Valbiotis SA 9.86 Million EUR -497.092%
TheraVet SA 1.64 Million EUR -3483.685%
Valerio Therapeutics Société anonyme 20.32 Million EUR -189.995%
DBV Technologies S.A. 89.4 Million EUR 34.09%
Genfit S.A. 54.8 Million EUR -7.523%
GeNeuro SA 14.35 Million EUR -310.432%
Innate Pharma S.A. 64.57 Million EUR 8.739%
Inventiva S.A. 120.18 Million EUR 50.97%
MaaT Pharma SA 21.59 Million EUR -172.835%
MedinCell S.A. 32.92 Million EUR -78.99%
OSE Immunotherapeutics SA 23.58 Million EUR -149.807%
Poxel S.A. 28.76 Million EUR -104.857%
GenSight Biologics S.A. 32.66 Million EUR -80.426%
Transgene SA 31.23 Million EUR -88.681%
Valneva SE 134.92 Million EUR 56.326%